首页> 外文期刊>Journal of drug delivery science and technology >A method for the prediction of drug content of poly(lactic-co-glycolic)acid drug carrier nanoparticles obtained by nanoprecipitation
【24h】

A method for the prediction of drug content of poly(lactic-co-glycolic)acid drug carrier nanoparticles obtained by nanoprecipitation

机译:一种预测纳米尺寸获得的聚(乳酸共甘油)酸药物载体纳米颗粒的药物含量的方法

获取原文
获取原文并翻译 | 示例
           

摘要

Poly(lactic-co-glycolic acid) drug loaded nanoparticles are applied successfully to increase the distribution and bioavailability of hydrophobic drug molecules, although the generally low drug content implies a limitation. Poly(lactic-co-glycolic acid) nanoparticles were prepared by nanoprecipitation to encapsulate model drugs, a series of alkyl-hydroxy-benzoate (parabens) from methyl-to octyl with increasing hydrophobicity to address the influence of drug property on the encapsulation. The drug content and encapsulation efficiency were found to be substantially different for the various parabens. The analysis of the miscibility of the polymer with parabens using their solubility parameters could not provide satisfactory explanation for the experimental findings.The treatment of nanoencapsulation however, as a partitioning process involving poly(lactic-co-glycolic acid) and aqueous phase led to a relationship between the drug content of the nanoparticles and the characteristic properties of the drug molecule. According to that both the high hydrophobicity and high aqueous solubility of the drug favour the efficacy of its encapsulation. The actual and also the achievable maximum drug content can be predicted and was tested in several systems. The above approach opens the way for more reasonable design of nanoparticle drug carrier in addition to the possible explanation for the drug content achievable for a given compound.
机译:虽然通常低药物含量意味着普遍含量低,但成功地施加了聚(乳酸二乙醇酸)药物负载纳米颗粒以增加疏水药物分子的分布和生物利用度,尽管通常低药物含量意味着限制。通过纳米沉淀制备聚(乳酸二乙醇酸)纳米颗粒以将模拟药物包封,从甲基 - 辛基中的一系列烷基 - 羟基苯甲酸酯(羟基苯甲酸酯)随着疏水性的增加,以解决药物性质对包封的影响。发现药物含量和包封效率对于各种羟基苯甲酸酯基本上不同。使用它们的溶解度参数对羟基苯甲酸酯的聚合物的混溶性分析不能为实验结果提供令人满意的解释。然而,纳米涂层的处理作为涉及聚(乳酸 - 共乙醇酸)和水相LED的分配过程纳米颗粒的药物含量与药物分子特性的关系及其特征。根据该药物的高疏水性和高水溶性,有利于其包封的疗效。可以预测实际和可实现的最大药物含量,并在几个系统中进行测试。除了可能的解释对于给定的化合物可实现的药物含量的可能解释,上述方法还为更合理的纳米粒子药物载体设计进行了纳米颗粒药物载体的方式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号